Scientists have finally watched influenza viruses break into living human cells in real time, catching the microscopic invaders as they latch on, glide across the surface and slip inside. Instead of a ...

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine ...

A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists ...

H5N1 avian influenza is highly pathogenic and has been devastating bird populations worldwide. It continues to do so, and is also moving into new animals, like skunks, bears, raccoons, cats, and dairy ...

The cold season is in full swing, throats are scratchy and noses are running. We feel ill and hope it is not the flu. The ...

Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study ...

Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study ...

Most influenza viruses enter human or animal cells through specific pathways on the cells’ surface. Researchers at the University of Zurich have now discovered that certain human flu viruses and avian ...

The influenza virus manipulates the body's gene regulation system to accelerate its own spread. A new study also shows that an already approved drug could help strengthen immune defenses -- though its ...

Severe COVID-19 raises lung cancer risk by 24%, study of 76 million Americans finds In A Nutshell People hospitalized with severe COVID-19 had roughly a 24 percent higher risk of developing lung ...

A Vero-cell-culture–derived trivalent influenza vaccine had a protective efficacy of 79% against antigenically matched influenza strains. Conventional egg-based influenza vaccines have several ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting marketing authorization for Flucelvax Tetra (Seqirus Netherlands BV), a ...